(Q36284501)

13 August 2017

1 reference

title

Treatment options for brain metastases from melanoma (English)

1 reference

13 August 2017

Robert R McWilliams

1

1 reference

13 August 2017

Ravi D Rao

2

1 reference

13 August 2017

Paul D Brown

3

1 reference

13 August 2017

Michael J Link

4

1 reference

13 August 2017

Jan C Buckner

5

1 reference

13 August 2017

language of work or name

1 reference

1 October 2005

1 reference

Expert Review of Anticancer Therapy

13 August 2017

1 reference

13 August 2017

5

1 reference

13 August 2017

5

1 reference

13 August 2017

809-820

1 reference

Metastatic pattern of malignant melanoma. A study of 216 autopsy cases

13 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Brain metastasis from melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

The current causes of death in patients with malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Seizure prophylaxis in patients with brain tumors: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Radiation Therapy for Brain Metastases from Malignant Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Malignant melanoma brain metastases. Review of Roswell Park Memorial Institute experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

An evaluation of the management of patients with cerebral metastases from malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Whole brain irradiation for patients with metastatic melanoma: a review of 87 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Radiation biology of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Brain metastases from malignant melanoma: conventional vs. high-dose-per-fraction radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

High-dose fraction radiation therapy for intracranial metastases of malignant melanoma: a comparison with low-dose fraction therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

An evaluation of the surgical management of melanoma of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

A randomized trial of surgery in the treatment of single metastases to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Surgery as palliative treatment for distant metastases of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Stereotactic radiosurgery for cerebral metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Stereotactic radiosurgery for malignant melanoma to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Gamma surgery for melanoma metastases in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Club de Cancérologie Cutanée.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Response of intracranial melanoma metastases to stereotactic radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Chemotherapy approaches to melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Treatment of brain metastases of malignant melanoma with temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

The effect of temozolomide-based chemotherapy in patients with cerebral metastases from melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Treatment of metastatic melanoma in the brain with temozolomide and thalidomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Safety and efficacy of high-dose interleukin-2 therapy in patients with brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Combined immunotherapy of malignant melanoma. Unusual survival following cerebral metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Biochemotherapy for metastatic melanoma with limited central nervous system involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.5.809

21 January 2018

Identifiers

DOI

10.1586/14737140.5.5.809

1 reference

release_fg752txd3bgllipvsqxpuag6qe

13 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fg752txd3bgllipvsqxpuag6qe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference